Additionally, a recent study reported that SLC22A3 polymorphisms might decrease the risk of coronary heart disease by against inflammatory response [27], which implied that the inflammation response may be affected by cg25313204 methylation on SLC22A3 in atherosclerosis. Here, SLC22A3 is linked to atherosclerosis.